ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ondansetron Hydrochloride Preservative Free, and when can generic versions of Ondansetron Hydrochloride Preservative Free launch?
Ondansetron Hydrochloride Preservative Free is a drug marketed by Accord Hlthcare, Am Regent, Apotex Inc, Avet Lifesciences, Baxter Hlthcare Corp, Eugia Pharma, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Hospira, Sandoz, Steriscience Speclts, Sun Pharm Inds Ltd, Taro Pharms Ireland, Teva, and Wockhardt. and is included in twenty NDAs.
The generic ingredient in ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the ondansetron hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ondansetron Hydrochloride Preservative Free
A generic version of ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE was approved as ondansetron hydrochloride by FRESENIUS KABI USA on December 26th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE?
- What are the global sales for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE?
- What is Average Wholesale Price for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE?
Summary for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 20 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 61 |
| Clinical Trials: | 11 |
| Patent Applications: | 1,391 |
| DailyMed Link: | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE at DailyMed |
Recent Clinical Trials for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Pennsylvania | Phase 3 |
| Pacira Pharmaceuticals, Inc | Phase 4 |
| Charles University, Czech Republic | Phase 4 |
See all ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE clinical trials
Pharmacology for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
| Drug Class | Serotonin-3 Receptor Antagonist |
| Mechanism of Action | Serotonin 3 Receptor Antagonists |
US Patents and Regulatory Information for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | ondansetron hydrochloride | INJECTABLE;INJECTION | 206845-001 | Mar 10, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Taro Pharms Ireland | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | ondansetron hydrochloride | INJECTABLE;INJECTION | 078014-001 | Mar 21, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | ondansetron hydrochloride | INJECTABLE;INJECTION | 202600-001 | Dec 21, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
